Homebiopharmaceutical

biopharmaceutical

Is It Too Late to Invest in Novavax Stock?

Is It Too Late to Invest in Novavax Stock?

October 20, 2022

JNJ Stock Rises as FDA Approves the Use of Teligen System in Spinal Operations

JNJ Stock Rises as FDA Approves the Use of Teligen System in Spinal Operations

October 20, 2022

NVS Stock Rises as Nilotinib, a Leukemia Medication Is Licensed by Novartis to the Un-Backed Medicines Patent Pool

NVS Stock Rises as Nilotinib, a Leukemia Medication Is Licensed by Novartis to the Un-Backed Medicines Patent Pool

October 20, 2022

Moderna Stock Slid as Omicron BA.1 Bivalent Vaccine Better Than the Initial Shot as a Fourth Booster

Moderna Stock Slid as Omicron BA.1 Bivalent Vaccine Better Than the Initial Shot as a Fourth Booster

October 20, 2022

Novavax Stock: Explaining Wednesday’s Decline

Novavax Stock: Explaining Wednesday’s Decline

October 19, 2022

Is Johnson & Johnson (Jnj) Stock Alpha Enough to Make It a Good Low Beta Stock?

Is Johnson & Johnson (Jnj) Stock Alpha Enough to Make It a Good Low Beta Stock?

October 19, 2022

Johnson and Johnson Stock Went Up After the Company Said It Would Report Earnings for the Third Quarter

Johnson and Johnson Stock Went Up After the Company Said It Would Report Earnings for the Third Quarter

October 17, 2022

Pfizer Stock Dips as It Denies CEO Won EU COVID-19 Vaccine Contract Through Texting

Pfizer Stock Dips as It Denies CEO Won EU COVID-19 Vaccine Contract Through Texting

October 10, 2022

Guggenheim Upgraded the Merck Stock to Buy, Noting the Company’s Projected Profits Growth.

Guggenheim Upgraded the Merck Stock to Buy, Noting the Company’s Projected Profits Growth.

October 10, 2022

JNJ Stock Fell as Long-Term Ulcerative Colitis Therapeutic Effects Were Highlighted.

JNJ Stock Fell as Long-Term Ulcerative Colitis Therapeutic Effects Were Highlighted.

October 10, 2022

« 1 … 5 6 7 8 9 … 16 »